Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $18,157 | 1,034 | 36.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $17,100 | 12 | 34.2% |
| Consulting Fee | $10,770 | 3 | 21.5% |
| Travel and Lodging | $2,841 | 24 | 5.7% |
| Unspecified | $786.66 | 5 | 1.6% |
| Education | $378.14 | 9 | 0.8% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $18,198 | 169 | $0 (2024) |
| ABBVIE INC. | $12,218 | 145 | $0 (2024) |
| Regeneron Pharmaceuticals, Inc. | $6,492 | 10 | $0 (2017) |
| Amgen Inc. | $2,274 | 149 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,819 | 65 | $0 (2023) |
| Janssen Biotech, Inc. | $1,540 | 100 | $0 (2024) |
| UCB, Inc. | $1,353 | 119 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,326 | 50 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $624.86 | 28 | $0 (2021) |
| Lilly USA, LLC | $622.97 | 54 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,483 | 73 | ABBVIE INC. ($750.43) |
| 2023 | $2,683 | 136 | AbbVie Inc. ($704.60) |
| 2022 | $2,181 | 139 | ABBVIE INC. ($382.64) |
| 2021 | $2,215 | 150 | Janssen Biotech, Inc. ($284.10) |
| 2020 | $1,244 | 80 | Amgen Inc. ($263.68) |
| 2019 | $10,159 | 108 | PFIZER INC. ($8,759) |
| 2018 | $7,767 | 205 | AbbVie, Inc. ($3,447) |
| 2017 | $22,299 | 196 | PFIZER INC. ($7,542) |
All Payment Transactions
1,087 individual payment records from CMS Open Payments — Page 1 of 44
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $7.71 | General |
| Category: Inflammation | ||||||
| 12/17/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $9.90 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $73.21 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $11.37 | General |
| Category: Immunology | ||||||
| 11/19/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $27.54 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $80.83 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $11.12 | General |
| Category: IMMUNOLOGY | ||||||
| 10/28/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $35.00 | General |
| Category: IMMUNOLOGY | ||||||
| 10/08/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $28.55 | General |
| Category: IMMUNOLOGY | ||||||
| 09/26/2024 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: Immunology | ||||||
| 09/19/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $17.92 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 09/19/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $7.92 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 09/05/2024 | SOBI, INC | KINERET (Drug) | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: IMMUNOLOGY | ||||||
| 09/03/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $29.84 | General |
| Category: IMMUNOLOGY | ||||||
| 08/29/2024 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $21.08 | General |
| Category: Immunology | ||||||
| 08/28/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: Inflammation | ||||||
| 08/27/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $35.00 | General |
| Category: IMMUNOLOGY | ||||||
| 08/15/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $13.96 | General |
| Category: IMMUNOLOGY | ||||||
| 08/14/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $18.52 | General |
| Category: Inflammation | ||||||
| 08/13/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $25.01 | General |
| Category: Bone Health | ||||||
| 08/13/2024 | Organon Llc | RENFLEXIS (Drug), HADLIMA | Food and Beverage | In-kind items and services | $20.48 | General |
| Category: INFLIXIMAB | ||||||
| 08/06/2024 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $9.80 | General |
| Category: Immunology | ||||||
| 08/01/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $31.83 | General |
| Category: IMMUNOLOGY | ||||||
| 07/30/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $12.24 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 07/23/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $7.11 | General |
| Category: IMMUNOLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A PHASE 3, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, | GlaxoSmithKline, LLC. | $786.66 | 5 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 618 | 10,245 | $435,610 | $217,441 |
| 2022 | 17 | 873 | 26,339 | $1.9M | $722,516 |
| 2021 | 24 | 1,158 | 27,801 | $2.0M | $918,303 |
| 2020 | 27 | 1,228 | 28,008 | $2.3M | $1.1M |
All Medicare Procedures & Services
76 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 89 | 8,820 | $297,840 | $161,370 | 54.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 182 | 410 | $77,900 | $36,410 | 46.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 117 | 177 | $23,718 | $10,555 | 44.5% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 34 | 79 | $16,533 | $3,815 | 23.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 105 | 263 | $12,887 | $2,653 | 20.6% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 22 | 22 | $3,168 | $1,600 | 50.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 24 | 24 | $864.00 | $704.64 | 81.6% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 45 | 450 | $2,700 | $332.58 | 12.3% |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2022 | 21 | 13,450 | $1.1M | $434,373 | 37.9% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 82 | 8,460 | $258,540 | $142,403 | 55.1% |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | Office | 2022 | 18 | 2,390 | $263,140 | $64,402 | 24.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 183 | 402 | $76,380 | $35,538 | 46.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 131 | 197 | $26,398 | $11,763 | 44.6% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2022 | 44 | 239 | $42,303 | $10,970 | 25.9% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2022 | 32 | 93 | $31,341 | $9,026 | 28.8% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 39 | 79 | $17,368 | $4,286 | 24.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 96 | 245 | $12,005 | $2,496 | 20.8% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 49 | 57 | $7,638 | $2,340 | 30.6% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2022 | 29 | 87 | $7,047 | $1,843 | 26.2% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 15 | 15 | $2,850 | $1,058 | 37.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 26 | 26 | $936.00 | $727.27 | 77.7% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2022 | 25 | 25 | $1,096 | $526.69 | 48.1% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 51 | 466 | $2,796 | $402.53 | 14.4% |
| J3489 | Injection, zoledronic acid, 1 mg | Office | 2022 | 14 | 70 | $5,670 | $341.61 | 6.0% |
| J7050 | Infusion, normal saline solution, 250 cc | Office | 2022 | 18 | 38 | $380.00 | $18.91 | 5.0% |
About Dr. Sanford Wolfe, DO
Dr. Sanford Wolfe, DO is a Rheumatology healthcare provider based in Dayton, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1255390233.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sanford Wolfe, DO has received a total of $50,032 in payments from pharmaceutical and medical device companies, with $1,483 received in 2024. These payments were reported across 1,087 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($18,157).
As a Medicare-enrolled provider, Wolfe has provided services to 3,877 Medicare beneficiaries, totaling 92,393 services with total Medicare billing of $3.0M. Data is available for 4 years (2020–2023), covering 76 distinct procedure/service records.
Practice Information
- Specialty Rheumatology
- Location Dayton, OH
- Active Since 03/20/2006
- Last Updated 01/08/2019
- Taxonomy Code 207RR0500X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1255390233
Products in Payments
- XELJANZ (Drug) $18,037
- Humira (Biological) $7,855
- KEVZARA SARILUMAB INJECTION (Biological) $6,661
- RINVOQ (Biological) $2,026
- COSENTYX (Biological) $1,489
- Cimzia (Drug) $1,341
- BENLYSTA (Biological) $1,326
- Enbrel (Biological) $1,025
- TREMFYA (Drug) $836.71
- EVENITY (Biological) $760.74
- ACTHAR (Biological) $711.30
- ORENCIA (Biological) $624.86
- Otezla (Drug) $446.39
- REMICADE (Biological) $409.51
- TALTZ (Drug) $393.96
- Actemra (Biological) $391.10
- SAPHNELO (Biological) $285.32
- SIMPONI ARIA (Biological) $242.88
- Tymlos (Biological) $238.15
- Prolia (Biological) $237.65
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Rheumatology Doctors in Dayton
Dr. Shobha Wani, M.d, M.D
Rheumatology — Payments: $3,636
Dr. Michael Stevens, Md, MD
Rheumatology — Payments: $709.55
Maria Thomas-John, Md, MD
Rheumatology — Payments: $311.67
Jon Ryan, Do, DO
Rheumatology — Payments: $39.33